| Section | Status | HCD | Name |
| 10.01.03 | Formulary |  |
Abatacept Orencia® |
| 10.01.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Adalimumab Biosimilars avaliable |
| 11.08.02 | Formulary | |
Aflibercept Eylea® |
| 13.05.01 | Formulary | |
Alitretinoin Toctino® |
| 10.01.03 | Formulary | |
Anakinra Kineret® |
| 13.05.03 | Formulary | |
Apremilast Otezla® |
| 10.01.03 | Formulary | |
Baricitinib Olumiant® |
| 10.01 | Formulary | |
Belimumab Benlysta® |
| 03.04.02 | Formulary | |
Benralizumab Fasenra® |
| 03.04.03 | Formulary | |
Berotralstat dihydrochloride Orladeyo® |
| 04.07.04.02 | Formulary | |
Botulinum Toxin Type A botox® |
| 13.05.03 | Formulary | |
Brodalumab Kyntheum® |
| 10.01.03 | Formulary | |
Certolizumab Pegol Cimzia® |
| 09.01.03 | Formulary | |
Deferasirox Exjade® |
| 09.01.03 | Formulary | |
Deferiprone Ferriprox® |
| 11.04.01 | Formulary | |
Dexamethasone intravitreal implant Ozurdex® |
| 13.05.03 | Formulary | |
Dupilumab Dupixent® |
| 09.01.04 | Formulary | |
Eltrombopag Revolade® |
| 02.08.01 | Formulary | |
Epoprostenol |
| 10.01.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 13.05.03 | Formulary | |
Etanercept Biosimilars avaliable |
| 11.04.01 | Formulary | |
Fluocinolone intravitreal implant Iluvien® |
| 11.03.01 | Formulary | |
Fusidic Acid |
| 10.01.03 | Formulary | |
Golimumab Simponi® |
| 10.01.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 13.05.03 | Formulary | |
Infliximab Biosimilars avaliable |
| 13.05.02 | Formulary | |
Ixekizumab Taltz® |
| 09.05.02.02 | Formulary | |
Lanthanum Fosrenol ® |
| 11.08.02 | Formulary | |
Ranibizumab |
| 04.09.03 | Formulary | |
Riluzole Rilutek® |
| 10.01.03 | Formulary | |
Risankizumab Skyrizi® |
| 13.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 09.01.03 | Formulary | |
Rituximab |
| 09.01.04 | Formulary | |
Rituximab idiopathic thrombocytopenia in adults |
| 10.01.03 | Formulary | |
Rituximab (rheumatology) Biosimilars avaliable |
| 09.01.04 | Formulary | |
Romiplostim Nplate® |
| 10.01.03 | Formulary | |
Sarilumab Kevzara® |
| 13.05.03 | Formulary | |
Secukinumab Cosentyx® |
| 06.05.01 | Formulary | |
Somatropin |
| 06.06.01 | Formulary | |
Teriparatide |
| 13.05.03 | Formulary | |
Tildrakizumab Ilumetri® |
| 10.01.03 | Formulary | |
Tocilizumab Biosimilars avaliable |
| 06.05.02 | Formulary | |
Tolvaptan |
| 13.05.03 | Formulary | |
Ustekinumab Stelara® |